Award
National Cancer Institute 5R01CA164719-12
Anti-cancer vaccine targeting the host-parasite interface during fluke infection
Recipient
GEORGE WASHINGTON UNIVERSITY
Award Amount
$151,875.00
Ceiling
$151,875.00
Awarded
September 16, 2025
Identifier
5R01CA164719-12
Research grant awarded to George Washington University for developing an anti-cancer vaccine targeting liver fluke infection, amounting to $151,875.
Description
This is a research grant award for developing an anti-cancer vaccine targeting liver fluke infection. The project involves vaccine development, immunology, and parasitology research. The award amount is $151,875, with a project duration from September 1, 2025, to August 31, 2026. The principal investigator is Professor Paul J Brindley at George Washington University.